The Gabelli Healthcare & Wellness Rx Trust (the “Fund”) (NYSE:GRX) announced the final terms of its Rights Offering that was initially announced on December 9, 2010. Pursuant to the Offer, the Fund will distribute to shareholders one transferable Right for each common share held on the record date of March 8, 2011.
Three Rights will enable a shareholder to purchase one additional common share at a price of $6.50 per share (the “Subscription Price”). The Rights are expected to be traded on the New York Stock Exchange (NYSE:GRX RT) and will be transferable. The subscription period will commence on March 8, 2011 (the record date) and terminate 35 days later on April 12, 2011 (the expiration date), unless extended for up to ten business days. Rights may be exercised at any time during the subscription period.
As in previous rights offerings by other Gabelli closed-end funds, record date shareholders who exercise their primary subscription Rights will be eligible for an over-subscription privilege entitling these shareholders to subscribe, subject to certain limitations and a pro-rata allotment, for any additional common shares not purchased pursuant to the primary subscription. In addition, under certain circumstances, the Fund may issue additional common shares to satisfy over-subscription requests by record date shareholders in excess of the common shares available for the over-subscription privilege. Rights acquired in the secondary market may not participate in the over-subscription privilege. The Board of Trustees has the right in its absolute discretion to eliminate the over-subscription privilege with respect to either or both primary over-subscription shares and secondary over-subscription shares if it considers it to be in the best interest of the Fund to do so. The Board of Trustees may make that determination at any time, without prior notice to Rights holders or others, up to and including the tenth day following the expiration date.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV